AQP7 and cancer: Interestingly, while exploring the specific mechanism of metformin in decreasing blood glucose level and even cancer inhibition, some researchers found that MAPK signaling pathway could be inhibited by metformin and pancreatic aquaporin 7 (AQP7) was then reactivated to allow insulin secretion [48].